- Current legislation on residue control has led to a decrease in the availability of authorized veterinary medicines.
- This has created adverse effects for public and animal health and welfare.
- There is a need to prioritize the dossier to resolve the crisis in availability, especially for minor uses and minor species.
- An urgent review of the Veterinary Medicines Directive is needed according to the task force on the availability of veterinary medicines.
- The incoming French Presidency is urged to give this issue the priority it needs.
